Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Filings indexed 747 across all filing types
Latest filing 2023-05-24 Regulatory Filings
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Dividend Updates
Regulatory Filings
2023-05-24 English
Change in Director(s)
Regulatory Filings
2023-05-24 English
Dividend
Regulatory Filings
2023-05-24 English
Financial Result Updates
Regulatory Filings
2023-05-24 English
Outcome of Board Meeting
Regulatory Filings
2023-05-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an invitation notice for an investor conference call scheduled to discuss the company's financial performance for the quarter and year ended 31st March 2023. It is addressed to stock exchanges and includes call details and participants. The document does not contain any financial data or results itself, but rather announces the upcoming call where such information will be discussed. This matches the definition of a Call Transcript (CT) document type, which includes full text transcripts of company conference calls. However, since this is only an invitation notice and not the transcript itself, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a regulatory announcement about the call, not the call transcript itself. The document length is short (2020 characters), and it is an announcement rather than the actual transcript or report. Therefore, the best classification is Regulatory Filings (RNS).
2023-05-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.